There is a need to develop diagnostic
and analytical tools that
allow noninvasive monitoring of bacterial growth and dissemination
in vivo. For such cell-tracking studies to hold translational value
to controlled human infections, in which volunteers are experimentally
colonized, they should not require genetic modification, and they
should allow tracking over a number of replication cycles. To gauge
if an antimicrobial peptide tracer, 99mTc-UBI29–41-Cy5, which contains both a fluorescent and a radioactive moiety,
could be used for such in vivo bacterial tracking, we performed longitudinal
imaging of a thigh-muscle infection with 99mTc-UBI29–41-Cy5-labeled Staphylococcus aureus. Mice were imaged using SPECT and fluorescence-imaging modalities
at various intervals during a 28 h period. Biodistribution analyses
were performed to quantitate radioactivity in the abscess and other
tissues. SPECT and fluorescence imaging in mice showed clear retention
of the 99mTc-UBI29–41-Cy5-labeled bacteria
following inoculation in the thigh muscle. Despite bacterial replication,
the signal intensity in the abscess only modestly decreased within
a 28 h period: 52% of the total injected radioactivity per gram of
tissue (%ID/g) at 4 h postinfection (pi) versus 44%ID/g at 28 h pi
(15% decrease). After inoculation, a portion of the bacteria disseminated
from the abscess, and S. aureus cultures were obtained
from radioactive urine samples. Bacterial staining with 99mTc-UBI29–41-Cy5 allowed noninvasive bacterial-cell
tracking during a 28 h period. Given the versatility of the presented
bacterial-tracking method, we believe that this concept could pave
the way for precise imaging capabilities during controlled-human-infection
studies.